Pulmonology clinical trials recruiting in New York

18 recruiting pulmonology trials match in New York. Showing 18.

• A Research Study to Advance the CF Therapeutics Pipeline for People Without ModulatorsRecruiting

  N/A · Nicole Hamblett · New Hyde Park, New York

• Study With Phage for CF Subjects With Pseudomonas Lung InfectionRecruiting

  Phase 2 · BiomX Ltd · Hawthorne, New York

• A Phase 2 Study Evaluating Safety and Tolerability of RCT2100 (CFTR mRNA) in Healthy Participants and in Participants With CFRecruiting

  Phase 2 · ReCode Therapeutics · Valhalla, New York

• Study to Check the Safety of Fazirsiran and Learn if Fazirsiran Can Help People With Liver Disease and Scarring (Fibrosis) Due to an Abnormal Version of Alpha-1 Antitrypsin ProteinRecruiting

  Phase 3 · Takeda · New York, New York

• Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)Recruiting

  Phase 3 · United Therapeutics · New Hyde Park, New York

• Lung Microbiome and Inflammation in Early COPDRecruiting

  N/A · NYU Langone Health · New York, New York

• A Follow-up Study to Test Long-term Treatment With Nerandomilast in People With Pulmonary Fibrosis Who Took Part in a Previous Study With NerandomilastRecruiting

  Phase 3 · Boehringer Ingelheim · Mount Kisco, New York

• Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic PhenotypeRecruiting

  Phase 3 · Sanofi · Flushing, New York

• Titrated Ambulatory Oxygen in Fibrotic ILD and COPD With Isolated Exertional HypoxemiaRecruiting

  N/A · State University of New York at Buffalo · Buffalo, New York

• Study to Evaluate Biological & Clinical Effects of Significantly Corrected CFTR Function in Infants & Young ChildrenRecruiting

  N/A · Sonya Heltshe · Buffalo, New York

• Standardizing Treatments for Pulmonary Exacerbations - Aminoglycoside StudyRecruiting

  Phase 4 · Chris Goss · New York, New York

• A Study to Find Out Whether BI 765423 Has an Effect on Lung Function in People With Idiopathic Pulmonary Fibrosis (IPF) With or Without Standard TreatmentRecruiting

  Phase 2 · Boehringer Ingelheim · New York, New York

• Phase 2 Study to Assess the Safety and Efficacy of ANG003Recruiting

  Phase 2 · Anagram Therapeutics, Inc. · Long Beach, California

• Symptoms and Functions in Patients With COPD and Chronic Bronchitis Switching From CIG to THSRecruiting

  N/A · Philip Morris Products S.A. · Dobrosloveni

• A Study to Evaluate the Long-Term Safety of Astegolimab in Participants With Chronic Obstructive Pulmonary Disease (COPD)Recruiting

  Phase 3 · Hoffmann-La Roche · Birmingham, Alabama

• Evaluation Of The Lung Microbiome In NTM BronchiectasisRecruiting

  N/A · NYU Langone Health · New York, New York

• A Study Assessing KB407 for the Treatment of Cystic FibrosisRecruiting

  Phase 1 · Krystal Biotech, Inc. · Hawthorne, New York

• WISPer: Evaluation of MTX-463 in Participants With Idiopathic Pulmonary Fibrosis (IPF)Recruiting

  Phase 2 · Mediar Therapeutics · New York, New York

Source: ClinicalTrials.gov. Recruitment status changes often — confirm on each study page.